Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy

European Journal of Pediatrics

Volumn 165, Issue 12, 2006, Pages 885-890

  Smets, Koenraad ^a   De Coen, Kris ^a   Dhooge, Ingeborg ^a   Standaert, Lieve ^b   Laroche, Sabrina ^c   Mahieu, Ludo ^c   Logghe, Noël ^d   Cossey, Veerle ^e   Boudewyns, An ^c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Medical Pedagogic Institute Spermalie   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d Stedelijk Ziekenhuis Roeselare   (Belgium)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Congenital cytomegalovirus infection; Ganciclovir; Sensorineural hearing loss; Treatment

Indexed keywords

GANCICLOVIR; LIVER ENZYME;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EVIDENCE BASED MEDICINE; HEARING IMPAIRMENT; HEARING LOSS; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; NEUROLOGIC DISEASE; NEUTROPENIA; NEWBORN; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT, NEWBORN; PATIENT SELECTION;

EID: 33750360458     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0192-2     Document Type: Article

References (40)

1. Attard-Montalto SP, English MC, Stimmler L, Snodgrass GJ (1993) Ganciclovir treatment of congenital cytomegalovirus infection: a report of two cases. Scand J Infect Dis 25:385-388
2. NIAID (2005) Neonatal CMV-ganciclovir follow-up study. Available at: http://www.clinicaltrials.gov/ct/show/NCT00031421. Accessed 1 June 2006
3. Barampouti F, Rajan M, Aclimandos W (2002) Should active CMV retinitis in non-immunocompromised newborn babies be treated? Br J Ophthalmol 86:248-249
4. Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, Britt WJ (2005) Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146:817-823
5. Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF (1997) Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99:409-414
6. Bradford RD, Cloud G, Lakeman AD, Boppana S, Kimberlin DW, Jacobs R, Demmler G, Sanchez P, Britt W, Soong S-j, Whitley RJ, National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group (2005) Detection of cytomegalovirus DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis 191:227-233
7. Burri M, Wiltshire H, Kahlert C, Wouters G, Rudin C (2004) Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl. Pediatr Infect Dis J 23:263-266
8. Crumpacker CS (1996) Ganciclovir. N Engl J Med 335:721-729
9. Demmler GJ (2003) Congenital cytomegalovirus infection treatment. Pediatr Infect Dis J 23:1005-1006
10. Faqi AS, Klug A, Merker HJ, Chahoud I (1997) Ganciclovir induces reproductive hazards in male rats after short-term exposure. Hum Exp Toxicol 16:505-511
11. Fischler B, Casswall TH, Malmborg P, Nemeth A (2002) Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr 34:154-157
12. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF (1997) Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 130:624-630
13. Guimaraes H, Trindade E, Mateus M, d'Orey C, Almeida A, Martins A, Souto A, Teixeira Santos N (1996) Traitement par ganciclovir des infections congénitales à cytomégalovirus. Arch Pédiatr 3:609-610
14. Hocker JR, Cook LN, Adams G, Rabalais GP (1990) Ganciclovir therapy of congenital cytomegalovirus pneumonia. Pediatr Infect Dis J 9:743-745
15. Kimberlin DW, Lin C, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kjell JM, Soong S-J, Whitley RJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143:16-25
16. Lanari M, Lazzorotto T, Venturi V, Papa I, Gabrielli L, Guerra B, Landini MP, Faldella G (2006) Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 117:e76-e83
17. Malinger G, Lev D, Zahalka N, Ben Aroia Z, Watemberg N, Kidron D, Ben Sira L, Lerman-Sagie T (2003) Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. Am J Neuroradiol 24:28-32
18. Meine Jansen CF, Toet MC, Rademaker CM, Ververs TF, Gerards LJ, van Loon AM (2005) Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir. J Perinat Med 33:364-366
19. Michaels MG, Greenberg DP, Sabo DL, Wald ER (2003) Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis J 22:504-508
20. Mittendorf R, Kuban K, Pryde PG, Gianopoulos JG, Yousefzadeh D (2005) Antenatal risk factors associated with the development of lenticulostriate vasculopathy in neonates. J Perinatol 25:101-107
21. Naessens A, Casteels A, Decatte L, Foulon W (2005) A serologic strategy for detecting neonates at risk for congenital cytomegalovirus infection. J Pediatr 146:194-197
22. Nigro G, Scholz H, Bartmann U (1994) Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr 124:318-322
23. Noyola DE, Demmler GJ, Nelson CT, Griesser C, Williamson WD, Atkins JT, Rozelle J, Tutcich M, Llorente AM, Sellers-Vinson S, Reynolds A, Bale JF, Gerson P, Yow MD, Houston Congenital CMV Longitudinal Study Group (2001) Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 138:325-331
24. Prober CG, Enright AM (2003) Congenital cytomegalovirus infections: hats off to Alabama. J Pediatr 143:4-6
25. Pyman B, Blamey P, Lacy P, Clark G, Dowell R (2000) The development of speech perception in children using cochlear implants: effects of etiologic factors and delayed milestones. Am J Otol 21:57-61
26. Reigstad H, Bjerknes R, Markestad T, Myrmel H (1992) Ganciclovir therapy of congenital cytomegalovirus disease. Acta Paediatr 81:707-708
27. Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF (2002) Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics 110:762-767
28. Rojo P, Ramos JT (2004) Ganciclovir treatment of children with congenital cytomegalovirus infection. Pediatr Infect Dis J 23:88-89
29. Sampath V, Narendran V, Donovan EF, Stanek J, Schleiss MR (2005) Nonimmune hydrops fetalis and fulminant fatal disease due to congenital cytomegalovirus infection in a premature infant. J Perinatol 25:608-611
30. Schulzke S, Bührer C (2006) Valganciclovir for treatment of congenital cytomegalovirus infection. Eur J Pediatr (epub ahead of print) DOI 10.1007/s00431-006-0109-0
31. Smith RJH, Bale JF Jr, White KR (2005) Sensorineural hearing loss in children. Lancet 365:879-890
32. Stronati M, Revello MG, Cerbo RM, Furione M, Rondini G, Gerna G (1995) Ganciclovir therapy of congenital human cytomegalovirus hepatitis. Acta Paediatr 84:340-341
33. Tanaka-Kitajima N, Sugaya N, Futatani T, Kanegane H, Suzuki C, Oshiro M, Hayakawa M, Futamura M, Morishima T, Kimura H (2005) Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pediatr Infect Dis J 24:782-785
34. Tricoire J, Rolland M, Regnier C (1993) Traitement par ganciclovir des infections congénitales à cytomégalovirus. Arch Fr Pediatr 50:173
35. Vallejo JG, Englund JA, Garcia-Prats JA, Demmler GJ (1994) Ganciclovir treatment of steroid-associated cytomegalovirus disease in a congenitally infected neonate. Pediatr Infect Dis J 13:239-241
36. Weng YH, Chu SM, Lien RI, Chou YH, Lin TY (2003) Clinical experience with ganciclovir and anti-cytomegalovirus immunoglobulin treatment for a severe case of congenital cytomegalovirus infection. Chang Gung Med J 26:128-132
37. Whitley RJ, Cloud G, Gruber W, Storch GA, Demmler GJ, Jacobs RF, Dankner W, Spector SA, Starr S, Pass RF, Stagno S, Britt WJ, Alford C Jr, Soong S-J, Zhou X-J, Sherrill L, FitzGerald JM, Sommadossi J-P, and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (1997) Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. J Infect Dis 75:1080-1086
38. Williamson WD, Demmler GJ, Percy AK, Catlin FI (1992) Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 90:862-866
39. Wutzler P, Thust R (2001) Genetic risks of antiviral nucleoside analogues-a survey. Antiviral Res 49:55-74
40. Yamashita Y, Outani Y, Kawano Y, Horikawa M, Matsuishi T, Hashimoto T (1990) Clinical analyses and short-term prognoses of neonates with subependymal cysts. Pediatr Neurol 6:375-378